A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Clinical trial NCT03172494 · COMPLETED
Trial details
- NCT number
- NCT03172494
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-26
- Primary completion
- 2019-06-14
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.